An increasing trend in for-profit entities and private equity investments in medicine could lead to a fragmented health care system, according to a position paper by the ACP.“The steady growth of corporate interest and influence in the health care sect…
Month: September 2021
Leading health journals publish joint editorial on ‘climate crisis’
In an unprecedented collaborative move, 220 leading health journals published a joint editorial on climate change, calling on world leaders to take swift action to protect the planet and safeguard public health.Never have so many journals published the…
NovaBay Pharmaceuticals to Present at the H.C. Wainwright 23nd Annual Global Investment Conference
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that management will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held September 13-15, 2021. The company presentation w…
Pay gap between women, men may be greater in ophthalmology than other specialty groups
Median payments made to male ophthalmologists in Ontario, Canada, in 2018 were higher than the median payments made to female ophthalmologists, according to a report.“In the literature, there are a lot of studies that have been done looking at the pay …
Berrocal: Hire more women
Representation of women among full-time tenure-line faculty members decreases with progression in rank, Audina M. Berrocal, MD, said in a keynote presentation at the Women in Ophthalmology Summer Symposium.Women accounted for 50% of assistant professor…
TriSalus Life Sciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled Drug Delivery in Uveal Melanoma Liver Metastases
DENVER & CHICAGO–(BUSINESS WIRE)– #cancer–TriSalus Life Sciences announces the first patient enrolled in the PERIO-01 clinical trial for adults with uveal melanoma liver metastases.
New imaging technique uses photonics for early diagnosis of bowel cancer
Early intervention could prevent many of the 160,000 deaths from colon cancer in Europe each year. Colonoscopies, the gold standard for spotting bowel cancer early, can still miss up to 20% of precancerous cells.
Ocular Therapeutix™ to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today an…
Azura Ophthalmics Appoints Biopharma Industry Veteran Steven Altschuler, M.D. as Chair of the Board
TEL AVIV, Israel & MELBOURNE, Australia–(BUSINESS WIRE)–Azura Ophthalmics Ltd. today announced the appointment of Steven M. Altschuler, M.D., as chair of its board of directors.
Aerie Pharmaceuticals to Participate in Upcoming Investor Conferences
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Aerie Pharmaceuticals Announces Appointment of Michael Bradley, Senior Director, Manufacturing
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Polygenic risk score no better at predicting psychosis outcomes than written reports, study finds
With the help of cutting-edge computer programs, researchers at the Icahn School of Medicine at Mount Sinai went through the genetic and medical records of more than 8,000 schizophrenia patients.
Global Juvenile Macular Degeneration Report on Drugs In Development, 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Juvenile Macular Degenerat…
Color Blind Women Face Unique Challenges, EnChroma Study Finds
BERKELEY, Calif.–(BUSINESS WIRE)– #colorishere–Color Blind Women Face Unique Challenges, EnChroma Study Finds, Including Skepticism, Delayed Diagnoses; Feeling Excluded From Some Activities
Lancement d’une nouvelle série de vidéos pédagogiques : Dr Horus* décrypte de manière décalée les maladies de l’œil sur YouTube
SAINT-LAURENT DU VAR, France–(BUSINESS WIRE)–Les vidéos ludiques de Dr Horus sur YouTube ont pour objectif de vulgariser et de mieux faire connaître les maladies de l’œil.
UK MHRA Grants GenSight Biologics’ LUMEVOQ® Ophthalmic Gene Therapy Promising Innovative Medicine Designation
PARIS–(BUSINESS WIRE)–GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central…
La MHRA accorde le statut de Promising Innovative Medicine au Royaume-Uni à la thérapie génique LUMEVOQ® de GenSight Biologics
PARIS–(BUSINESS WIRE)–GenSight Biologics (Paris:SIGHT) (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurodégé…
PANORAMA trial results show efficacy of proactive anti-VEGF treatment for NPDR
New results suggest that proactive treatment of severe nonproliferative diabetic retinopathy with aflibercept injections may lead to improvement of disease severity.Study results from the PANORAMA trial also suggest that these injections can prevent no…
Corneal cross-linking, robotics, top OSN cover stories
Corneal cross-linking and the potential of robotics are the topics of the best performing cover stories so far in 2021.Read the five best-performing cover stories from the first 8 months of the year below:US corneal cross-linking specialists aim to bri…
UCLA researchers receive $1 million to develop novel CAR T-cell therapies for melanoma
Cristina Puig-Saus, PhD, and Daniel S. Shin, MD, PhD, of UCLA Jonsson Comprehensive Cancer Center received a $1 million award from the U.S. Department of Defense for research into novel cell therapies for rare melanomas.The Translational Research Award…